Literature DB >> 7062181

Epidemiologic study of necrotizing enterocolitis among low-birth-weight infants. Absence of identifiable risk factors.

R M Kliegman, M Hack, P Jones, A A Fanaroff.   

Abstract

Necrotizing enterocolitis has been associated with a variety of perinatal problems which have been purported to be risk factors predisposing the neonate to NEC. The present investigation compares the perinatal histories of 48 low-birth-weight infants (less than 1,500 gm) with NEC to those of 553 high-risk infants of equivalent birth weight who did not have NEC but who were present in the nursery during a four-year observation period. The two populations were equivalent with regard to maternal factors such as socioeconomic status, education, race, and age. Both the antenatal and intrapartum risk scores were similar, as were the position of presentation and mode of delivery. The incidence of pre-eclampsia, prolonged rupture of the membranes, and placenta previa was also equivalent. Birth weight and gestational age were identical, as well as intrauterine growth retardation and low Apgar scores. The placement of umbilical artery catheters or the performance of exchange transfusions were not more frequent among patients with NEC. Infants who developed NEC demonstrated significantly different incidences of only three variables. Mothers of these infants were usually married, and their infants had less respiratory distress syndrome; the only adverse factor present more frequently was abruptio placenta. These data raise further questions concerning the significance of previously reported risk factors of NEC.

Entities:  

Mesh:

Year:  1982        PMID: 7062181     DOI: 10.1016/s0022-3476(82)80456-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  33 in total

1.  Temporal and seasonal variations in incidence of stage II and III NEC-a 28-year epidemiologic study from tertiary NICUs in Connecticut, USA.

Authors:  Darius Javidi; Zigeng Wang; Sanguthevar Rajasekaran; Naveed Hussain
Journal:  J Perinatol       Date:  2021-02-15       Impact factor: 2.521

Review 2.  Neonatal necrotising enterocolitis.

Authors:  M Rohatgi; S Chandna
Journal:  Indian J Pediatr       Date:  1988 Nov-Dec       Impact factor: 1.967

3.  Defining quality of care indicators for neonatal intensive care units independent of maternal risk factors.

Authors:  I Ekelem; H W Taeusch
Journal:  J Natl Med Assoc       Date:  1990-05       Impact factor: 1.798

4.  Risk factors for necrotising enterocolitis: the influence of gestational age.

Authors:  P J Beeby; H Jeffery
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

5.  Comparison of serogrouping and polyacrylamide gel electrophoresis for typing Clostridium difficile.

Authors:  M Delmée; Y Laroche; V Avesani; G Cornelis
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

6.  A case control study of necrotizing enterocolitis occurring over 8 years in a neonatal intensive care unit.

Authors:  M De Curtis; C Paone; G Vetrano; G Romano; R Paludetto; F Ciccimarra
Journal:  Eur J Pediatr       Date:  1987-07       Impact factor: 3.183

7.  Surgery in very low birthweight infants.

Authors:  E M Kiely
Journal:  Arch Dis Child       Date:  1984-08       Impact factor: 3.791

Review 8.  Pathogenesis of NEC: Role of the innate and adaptive immune response.

Authors:  Timothy L Denning; Amina M Bhatia; Andrea F Kane; Ravi M Patel; Patricia W Denning
Journal:  Semin Perinatol       Date:  2016-12-09       Impact factor: 3.300

9.  Antenatal Exposure to Magnesium Sulfate Is Associated with Reduced Cerebellar Hemorrhage in Preterm Newborns.

Authors:  Dawn Gano; Mai-Lan Ho; John Colin Partridge; Hannah C Glass; Duan Xu; A James Barkovich; Donna M Ferriero
Journal:  J Pediatr       Date:  2016-07-22       Impact factor: 4.406

10.  Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin.

Authors:  F Gonzalez-Crussi; W Hsueh
Journal:  Am J Pathol       Date:  1983-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.